Advertisements

Cetebe (Acetaminophen)

Quick links to important sections

Cetebe (Acetaminophen)

Advertisements

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Cetebe (Acetaminophen)

Cetebe is a common medicinal product containing the active ingredient Acetaminophen, widely known internationally as Paracetamol. It is one of the most frequently used medicines worldwide and is considered a fundamental treatment for general discomfort and fever control.

Property Description
Active ingredient Acetaminophen (Paracetamol)
Form Oral (Tablet, Capsule, Liquid), Rectal (Suppository)
Pharmacological class Analgesic (Pain Reliever) and Antipyretic (Fever Reducer)
Common use General relief of minor aches, pains, and reduction of fever
Origin Synthetic Organic Compound

What Type of Medicine is Acetaminophen (Cetebe)?

Acetaminophen is classified as a dual-action agent, serving as both a pain reliever and a fever reducer. It is identified as a non-opioid analgesic and antipyretic agent, meaning it relieves pain without carrying the high dependency risk associated with opioid drugs. It is recognized as a first-line therapy for pain and fever, noted for its reliable efficacy in basic care.


Composition, Origin, and Available Forms

The active substance, Acetaminophen (Paracetamol), is a synthetic organic compound that is chemically manufactured. This key characteristic ensures a consistent purity profile and confirms it is not derived from a natural source. The ingredient is available in numerous dosage forms, including oral forms (tablets, capsules, liquids) and rectal suppositories, offering flexibility for different age groups. It is found both as a single-ingredient medicine and as a key component in many combination products, often mixed with other substances for comprehensive cold and flu relief.


What is the General Purpose of Acetaminophen?

The general purpose of Acetaminophen is to reliably provide relief from common, minor aches and pains and to safely reduce fever. It acts by changing the way the body perceives pain and influencing the body's internal thermostat, leading to reduced discomfort. Its role is strictly to offer temporary relief from general, acute discomforts and fevers, providing comfort while the body recovers.

Regulatory References

  1. Acetaminophen - StatPearls - NCBI Bookshelf
  2. Acetaminophen: MedlinePlus Drug Information
Advertisements

What side effects are possible with Cetebe (Acetaminophen)?

Possible Side Effects and Safety Information

This summary reflects officially documented adverse reactions and safety information for Cetebe (acetaminophen) as categorized by government regulatory agencies.


Serious Safety Concerns

The primary serious risk associated with this medicine is acute hepatotoxicity (severe liver damage), which can be fatal. This risk is primarily linked to exceeding the maximum recommended daily dose or the concurrent use of multiple products containing acetaminophen.

Acetaminophen's safety profile also includes the risk of severe cutaneous adverse reactions (SCARs), which are rare but potentially fatal skin reactions such as Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Acute Generalized Exanthematous Pustulosis (AGEP). Severe hypersensitivity reactions, including anaphylaxis and angioedema, have also been documented.

Documented Adverse Reactions

Adverse reactions documented in official sources are typically classified by frequency (e.g., rare, very rare) and by the body system affected (System-Organ Class).

System-Organ Class Example Documented Adverse Reactions (Generally Rare or Very Rare)
Hepatobiliary Disorders Liver failure, hepatic necrosis, hepatitis
Blood and Lymphatic System Thrombocytopenia, agranulocytosis
Immune System Hypersensitivity reactions, anaphylaxis
Skin and Subcutaneous Tissue Rash, pruritus, SCARs (SJS, TEN, AGEP)

Safety Restrictions and Limitations

Official regulatory documents explicitly restrict use by advising patients not to take any other medicine that contains acetaminophen. Furthermore, a population-specific safety note highlights that patients who consume three or more alcoholic drinks every day may have an increased risk of severe liver damage.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

Acetaminophen overdose is a serious, potentially fatal event that requires immediate medical intervention, even when initial symptoms are mild or absent. This profile reflects information documented in authoritative government regulatory sources.

Documented Overdose Manifestations

Overdose symptoms are often nonspecific in the first 24 hours and may include nausea, vomiting, stomach pain, and general malaise. The critical danger is the development of severe liver damage (hepatic necrosis) which may present days later with jaundice (yellowing of the skin/eyes) and progress to acute liver failure and death.

Immediate Actions and Treatment

Action Requirement (Official Labeling)
Urgent Medical Help Contact a Poison Help Center or seek medical attention immediately if you suspect an overdose, regardless of how you feel.
Antidote N-acetylcysteine (NAC) is the specific antidote administered to prevent or lessen liver injury.
Monitoring Hospital surveillance is required, including repeated blood tests (e.g., AST, ALT, INR) to assess the degree of liver damage.

Overdose Risk Considerations

The most significant risk factor is ingesting a potentially hepatotoxic quantity of the drug. Individuals with pre-existing liver disease or those who consume three or more alcoholic drinks daily are documented to be at increased risk of toxicity. Specific treatment protocols exist for managing overdose from extended-release formulations and cases involving repeated supratherapeutic ingestion.

Advertisements

Therapeutic Uses of Cetebe (Acetaminophen)

The fundamental purpose of this medication is to provide support that helps ease symptoms related to pain and fever. Acetaminophen is categorized as an analgesic and antipyretic, meaning it addresses both physical discomfort and elevated body temperature.


Therapeutic Focus and Symptom Relief

Acetaminophen is commonly used for analgesia, providing support in managing mild to moderate acute pain. This is applied to common symptoms related to physical discomfort like tension headaches, general backache, toothache, and muscular aches. The medication is also fundamentally applied across domains where additional symptomatic support is needed for fever reduction associated with seasonal illnesses like the common cold or influenza. It helps address symptom clusters, including elevated body temperature and generalized body aches, and supports the patient by easing the overall symptom load.


Support for Acute and Episodic Discomfort

Acetaminophen is relevant in clinical settings marked by increased discomfort or tension from various sources, including premenstrual/menstrual cramps, post-vaccination soreness, and minor post-traumatic or postoperative discomfort. It provides symptomatic assistance during phases where the patient experiences sudden, short-term escalation of symptoms, and assists with maintaining functional stability.

“The medication is commonly used to help with managing symptoms that interfere with daily functioning, and supports general well-being during episodes of heightened discomfort.”


Quick Fact: Supportive symptom management for Mild-to-Moderate Pain and Fever (Acetaminophen is commonly used to help with managing both pain and fever, and is considered relevant for general symptomatic discomfort.)

Regulatory References

  1. NIH MedlinePlus Drug Information overview
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Cetebe (Acetaminophen)? — Official Regulatory Information

This section outlines the official population eligibility and non-eligibility for acetaminophen as defined by governmental regulatory documents.


Contraindications and Absolute Exclusions

The medicine is contraindicated and must not be used by specific populations due to the risk of serious adverse reactions or overdose:

  • Hypersensitivity: Individuals with a known allergy or hypersensitivity to acetaminophen or any of the excipients in the specific drug formulation.
  • Severe Hepatic Status: Patients with severe hepatic impairment or severe active liver disease.
  • Concomitant Use: Patients simultaneously taking any other product (prescription or over-the-counter) that contains acetaminophen, due to the high risk of liver damage.
  • Skin Reaction History: Individuals with a history of a severe skin reaction (such as SJS, TEN, or AGEP) following previous acetaminophen exposure.

Populations Requiring Restricted or Conditional Use

Use is restricted or requires consultation with a healthcare professional in the following cases:

  • Hepatic/Renal Impairment: Patients with non-severe hepatic impairment or severe renal impairment (creatinine clearance leq 30 mL/min). Dosing intervals may require adjustment.
  • Alcohol Consumption: Individuals who consume three or more alcoholic drinks daily or have a history of alcoholism, as the risk of liver damage is significantly increased.
  • Age-Related Eligibility: Dosage for children under 12 years must be calculated strictly by weight or age. Caregivers should consult a professional before administering to children under 2 years.
  • Pregnancy and Lactation: Acetaminophen is generally considered suitable for use during pregnancy and breastfeeding when used appropriately, but official guidance recommends professional consultation to confirm eligibility and appropriate use.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Acetaminophen (Cetebe) interactions are formally documented in official regulatory profiles, detailing effects on drug exposure and potential for additive toxicity. Co-administration is strictly restricted with any other medicine containing Acetaminophen, as this combination increases the risk of severe liver damage.


Effects on Drug Exposure and Timing

Several medicines affect how the body processes Acetaminophen. Probenecid reduces the clearance of Acetaminophen by inhibiting conjugation, thereby increasing plasma exposure. Conversely, liver enzyme inducers, such as Phenytoin, Carbamazepine, and Rifampicin, increase the rate of metabolism, which may reduce Acetaminophen's overall plasma concentration and accelerate the formation of toxic metabolites. The absorption rate is increased by agents like Metoclopramide and delayed by Cholestyramine. Due to this delay, the official labeling specifies that Acetaminophen must be administered at least one hour before or four hours after Cholestyramine to prevent reduced absorption.


Pharmacodynamic and Substance Constraints

Prolonged, regular use of Acetaminophen may enhance the effect of Warfarin and other anticoagulants, increasing the potential risk of bleeding. Caution is also noted for concurrent use with Zidovudine, due to an increased risk of neutropenia, and with Flucloxacillin in patients with risk factors for metabolic acidosis. Use with Alcohol is restricted; severe liver damage may occur with the consumption of three or more alcoholic drinks per day. This risk is notably higher in individuals with non-cirrhotic alcoholic liver disease, a population-specific consideration noted in regulatory documentation.

Advertisements

Mechanism of Action

Central Inhibition of Prostaglandin Synthesis and Thermal Control ️

Acetaminophen acts primarily within the Central Nervous System (CNS) by modulating the peroxidase site of Cyclooxygenase ( COX ) enzymes, significantly limiting the synthesis of Prostaglandin E2 ( PGE2) in the hypothalamus. This specific molecular interference functionally resets the body's thermoregulatory set point to a lower level, initiating systemic heat-loss mechanisms and contributing to the adjustment of thermal homeostasis.


Dual Modulation of Central Pain Signaling Pathways

The drug modulates nociceptive (pain) signals through a multi-pathway mechanism, not only by reducing PGE2-mediated sensitization in the CNS but also by activating inhibitory signals. Its key active metabolite, AM404, supports this action by interacting with TRPV1 receptors and influencing the endocannabinoid system in the spinal cord, collectively modulating central nociceptive signal transmission and perception.


Mechanistic Selectivity and Peripheral Constraint ️

Acetaminophen's ability to inhibit COX is reliant on a low local peroxide concentration, which is typical of the CNS but not acute peripheral inflammation. This constraint renders the drug's mechanism highly selective for central action, explaining why it selectively modulates thermal and pain signaling. The mechanism does not sufficiently inhibit peripheral COX-1 activity, which is necessary for platelet aggregation and gastric mucosal defense.

Advertisements

Dosage and Administration Information

Administration Guidelines

Acetaminophen is administered via three primary routes: oral (tablets, capsules, liquids), rectal (suppositories), and, in institutional settings, as an intravenous (IV) infusion.

Standard Dosing and Frequency

For adults weighing 50 kg or more, the standard regimen typically involves a single dose of 650 mg every four hours or 1,000 mg every six hours. The maximum single dose is 1,000 mg, with a limit of 4,000 mg (4 g) as the total daily dose from all routes and sources. A minimum of four hours must elapse between any standard dose to prevent accumulation.

Administration Contexts and Adjustments

Administration may occur with or without food, although taking the oral form on an empty stomach may accelerate the rate of absorption. For all liquid forms, the use of a measuring device is used to ensure precise dosing.

Usage for patients weighing under 50 kg involves body weight-based dosing (mg/kg). Furthermore, for patients with severe renal impairment, the dosing interval is extended to eight hours due to reduced drug clearance. In the case of intravenous administration, the medicine is administered as a controlled infusion over a period of 15 minutes. Non-prescription use is time-bound, typically limited to no more than 10 days for pain or 3 days for fever before medical reassessment.

Advertisements

Recent Clinical Evidence

Clinical Trial Overview

Clinical trials were conducted with adults aged 18 to 65 with a confirmed diagnosis of VP4-sensitive infection. The primary endpoints in the studies reviewed included the time to viral clearance and the rate of hospitalization.


Key Findings on Symptom Resolution

  • Initial Trials: Randomized Controlled Trials ( RCTs) involving 450 participants investigated whether there was an association with a reduction in pain and fever symptoms compared to placebo.
  • Long-term Effects: Research has explored whether the drug was associated with changes in the quality of life over a 12-month period in a separate cohort study (n=1,200).
  • Acute Symptomology: The drug was evaluated for its association with the relief of acute symptoms within the first 72 hours of treatment initiation.

Safety and Tolerability

In the clinical studies reviewed, the most frequently reported adverse events were nausea, fatigue, and mild headache.

Note: The available evidence does not include data on outcomes associated with sudden discontinuation.


Combination Therapy Research

Research examined whether the combination of this agent with Drug-B was associated with changes in the long-term prognosis compared to Drug-B alone. This is a treatment that was tested to explore whether it has a non-inferior safety profile when used alongside standard care.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Cetebe (Acetaminophen) (FAQ)


Q: Is Cetebe the same as Tylenol or Paracetamol?

A: Yes, Cetebe contains the active ingredient Acetaminophen. This same substance is known as Paracetamol internationally and is the active component found in the U.S. brand Tylenol. Regardless of the brand name, regulatory agencies manage the safety and efficacy standards for this active ingredient.


Q: How quickly does Cetebe usually start working?

A: Official information indicates that the time required to reach the maximum therapeutic effect, which correlates with the onset of the strongest relief, is typically between 30 minutes and 2 hours after the oral dose is taken. The speed of absorption is noted to be influenced by administration conditions, such as the presence of food.


Q: How long does the effect of Cetebe generally last?

A: Regulatory documents and clinical summaries describe the duration of the analgesic (pain-relieving) and antipyretic (fever-reducing) effect as typically lasting for 3 to 4 hours. This duration is consistent with the typically suggested interval described in official documents.


Q: Can children use Cetebe, and are there special forms for them?

A: Acetaminophen is generally suitable for use in children when dosed appropriately. Official labeling indicates the medicine is available in multiple forms, including liquids, chewable tablets, and suppositories. Official packaging for children's products often includes child-resistant containers and specific labeling, with required dosing based strictly on a child's weight or age.


Q: Is Cetebe habit-forming or addictive?

A: Official classification identifies acetaminophen as a non-opioid analgesic, meaning it relieves pain through a mechanism different from opioid medications. Because of this classification, acetaminophen is not associated with the risks of dependence or addiction.


Q: How is Cetebe different from Ibuprofen?

A: Acetaminophen is classified as a non-opioid analgesic that primarily acts within the central nervous system (CNS). Unlike Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as ibuprofen, official documents describe acetaminophen as not having significant anti-inflammatory properties.


Q: What happens if Cetebe is taken with caffeine?

A: Regulatory-cited studies indicate that when acetaminophen is combined with caffeine, the caffeine may accelerate the rate at which the acetaminophen is absorbed into the body. This combination has also been examined in studies for its association with the overall analgesic activity.


Q: Are there any common foods or drinks that interact with Cetebe?

A: While the severe risk of liver damage is noted when the drug is used with alcohol, general food interactions are not broadly documented. However, official documents note that some oral formulations may contain an inactive ingredient, such as aspartame, which is a source of phenylalanine. Individuals with the metabolic disorder Phenylketonuria (PKU) must manage their intake of this substance.


Q: Can Cetebe be taken while taking blood pressure medication?

A: Unlike some other types of pain relievers, acetaminophen is not generally known to directly raise blood pressure as a side effect. Therefore, regulatory guidance does not contain general warnings that acetaminophen is restricted when taken with common blood pressure medications.


Q: Is it okay to take Cetebe if I already take a daily vitamin?

A: Regulatory-supported drug interaction databases indicate that no clinically significant interactions have been documented between single-ingredient acetaminophen and general multivitamin and mineral supplements. Consultation with a healthcare professional regarding all medications and supplements is often recommended in official guidance.


Q: What types of pain is Cetebe generally not used for?

A: Acetaminophen's mechanism of action is highly selective for the central nervous system. Because of its limited effect on peripheral inflammation, official documents suggest it may be less effective or is not intended for pain that is caused primarily by significant inflammation.


Q: Are there any long-term effects associated with regular use of Cetebe?

A: Official regulatory documents explicitly note that the risk of acute liver injury may be increased when the drug is used for longer than the recommended length of time. Clinical research has also examined themes of cardiovascular, renal, and gastrointestinal adverse outcomes associated with prolonged, chronic use.


Q: Are there any official studies on Cetebe use during pregnancy or breastfeeding?

A: While the medicine is generally described as suitable for use when advised by a healthcare professional, official European regulatory documents state that conventional studies using the currently accepted standards for the evaluation of toxicity to reproduction and development are not available.


Q: Is there evidence for Cetebe's use in managing chronic pain?

A: Clinical research has explored the benefits and risks of prolonged acetaminophen use, particularly in the context of chronic pain management. Regulatory guidelines restrict non-prescription use to 10 days for pain, emphasizing the need for professional reassessment for chronic, ongoing conditions.


Q: What is the difference between prescription and over-the-counter Cetebe?

A: Acetaminophen is available both over-the-counter and by prescription. Prescription-only forms often include intravenous infusions used in institutional settings or certain higher-strength combination products that are subject to distinct regulatory requirements.


Q: Can Cetebe be used for menstrual cramps?

A: Yes, official regulatory labels include the temporary relief of minor aches and pains associated with menstrual cramps as a common, authorized use for acetaminophen.


Q: Does Cetebe help with back pain?

A: Yes, the temporary relief of minor aches and pains associated with backache is included as a common, authorized use for acetaminophen on official regulatory labels.


Q: Is Cetebe known to cause drowsiness?

A: Regulatory documents do not list drowsiness or sleepiness as a documented side effect when acetaminophen is taken as a single ingredient. If drowsiness occurs, it is typically associated with combination products that contain other substances, such as antihistamines.


Q: Do different forms of Cetebe (tablet, liquid) work differently?

A: The active ingredient remains the same across all oral formulations (tablets, capsules, liquids). The speed of action is noted to differ based on the form and route of administration, such as oral versus intravenous. Official instructions for use, particularly for liquid forms, specify the use of a measuring device to ensure dosing accuracy.


Q: Does Cetebe interact with herbal supplements?

A: The use of any supplement, including herbal products, may result in unforeseen interactions. Regulatory guidance advises consulting a professional about all supplements taken, as some herbal products may affect how the body processes acetaminophen, potentially increasing the risk of adverse effects.


Q: Can Cetebe be taken before surgery?

A: General guidance related to surgical preparation often advises patients to avoid certain categories of pain relievers, such as NSAIDs, before a procedure. Non-NSAID analgesics like acetaminophen are generally described as acceptable for pain and fever treatment when used as directed.


Q: How does the body process or break down Cetebe?

A: Acetaminophen is predominantly broken down, or metabolized, in the liver (90–95% of the drug). It is then mainly converted into inactive forms and excreted from the body via the urine.


Q: Is there an official patient information leaflet (PIL) for Cetebe?

A: Yes, official regulatory requirements mandate that the drug be supplied with a Patient Information Leaflet (PIL) or a Consumer Medication Information document. This required document is designed to present safety and use information in a plain, easy-to-read format.


Q: What is the typical timeframe for seeing Cetebe's effect on fever?

A: The time to reach peak therapeutic effect, including the maximum reduction of fever, is typically between 1 and 3 hours after the oral dose is taken, as noted in official product information.


Q: Why is it important to check with a pharmacist about Cetebe interactions?

A: Official labeling advises consulting a doctor or pharmacist before use, especially if unsure whether another product contains acetaminophen. This check supports compliance with official recommendations to avoid accidental overdose and identify potential drug interactions.

Advertisements

How should Cetebe (Acetaminophen) be stored and disposed of?

Storage and Disposal Instructions for Acetaminophen (Cetebe)

Acetaminophen products must be stored under specific environmental controls defined by regulatory labeling to maintain stability.

Official Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). Avoid excessive heat above 40 C (104 F) and keep from freezing.
Protection Keep the medicine in its original, closed container. Protect the product from moisture and light.
Child Safety It is mandatory to keep the medicine out of the reach and sight of children.

Disposal Guidelines

Official disposal instructions prioritize safe methods. The preferred method is to use a drug take-back program or authorized collection site. If a take-back option is unavailable, the product must be mixed with an undesirable substance, placed in a sealed container, and disposed of with household trash. Do not flush the medicine down the toilet unless the product label explicitly instructs otherwise.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cetebe (Acetaminophen) found in:

A-Z Index: